The Effectiveness of Maintenance Electroconvulsive Therapy
DOI:
https://doi.org/10.51338/rppsm.2021.v7.i2.210Keywords:
Costs and Cost Analysis, Electroconvulsive Therapy, Length of Stay Mental Disorders/therapy, Patient Admission, Treatment OutcomeAbstract
Introduction: Electroconvulsive therapy (ECT) is a safe and effective treatment for treatment resistant severe mental disorders. However, it has a high relapse rate, following the acute course (A‑ECT). Maintenance treatment is recommended to increase remission rate and duration. Maintenance ECT (M‑ECT) is an option, although under‑prescribed. The aim of this study was to assess M‑ECT effectiveness in reducing number and duration of hospital admissions, as well as associated costs, in patients with severe mental disorders. Mirror study comparing number and duration of hospital admissions before and after first M‑ECT.
Methods: Information was gathered for demographic and technical data, and drug dosing. Mean cost before and after the initiation of M‑ECT was compared. All treatments were performed with a MECTA spECTrum 5000QÒ. Statistical analysis was performed using SPSS 22.
Results: A total of 16 patients were enrolled. The mean number of M‑ECT treatments was 41.25 with a mean duration of 23 months. Treatment frequency was mainly once a month. A statistically significant decrease was found for number of admissions (Mdn=2.0 before and Mdn=0.0 after) and for total days in admission (Mdn=86.0 before and Mdn=14.5 after). Marginally significant results were found for antidepressive dosage, with higher dosages in the after initiation period. No significant results were found for antipsychotic dosage variation. The mean cost per patient, before and after initiation of M‑ECT, was respectively 10 621€ and 5 653€.
Conclusão: In our sample, we found that M‑ECT significantly reduces number of admissions and days in admission. Initiating M‑ECT treatment decreased cost per patient by 47%.
Downloads
References
Rabheru K. Maintenance electroconvulsive therapy (M-ECT) after acute response: examining the evidence for who, what, when, and how? J ECT. 2012;28:39-47. doi: 10.1097/YCT.0b013e3182455758.
Watts BV, Groft A, Bagian JP, Mills PD. An examination of mortality and other adverse events related to electroconvulsive therapy using a national adverse event report system. J ECT, 2011;27:105-108. doi: 10.1097/YCT.0b013e3181f6d17f.
Babuskova, D., Zwinderman, A. H., & Linszen, D. H. , Electroconvulsive therapy for the treatment of clozapine nonresponders suffering from schizophrenia--an open label study. Eur Arch Psychiatry Clin Neurosci. 2004;254:372-379. doi: 10.1007/s00406-004-0517-y.
UK ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet. 2003;361:799-808. doi: 10.1016/S0140-6736(03)12705-5
Haq AU, Sitzmann AF, Goldman ML, Maixner DF, Mickey BJ. Response of depression to electroconvulsive therapy: a meta-analysis of clinical predictors. J Clin Psychiatry. 2015;76:1374-1384. doi: 10.4088/JCP.14r09528.
Milev RV, Giacobbe P, Kennedy SH, Blumberger DM, Daskalakis ZJ, Downar J,et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 4. Neurostimulation Treatments. Can J Psychiatry. 2016;61:561-575. doi: 10.1177/0706743716660033.
Ward HB, Szabo ST, Rakesh G. Maintenance ECT in schizophrenia: A systematic review. Psychiatry Res. 2018;264:131-142. doi: 10.1016/j.psychres.2018.03.033.
Shibasaki C, Takebayashi M, Fujita Y, Yamawaki S. Factors associated with the risk of relapse in schizophrenic patients after a response to electroconvulsive therapy: a retrospective study. Neuropsychiatr Dis Treat. 2015;11:67-73. doi: 10.2147/NDT.S74303
Jelovac A, Kolshus E, McLoughlin DM. Relapse following successful electroconvulsive therapy for major depression: a meta-analysis. Neuropsychopharmacology. 2013;38:2467-2474. doi: 10.1038/npp.2013.149
Trevino K, McClintock SM, Husain MM. A review of continuation electroconvulsive therapy: application, safety, and efficacy. J ECT. 2010; 26:186-195. doi: 10.1097/YCT.0b013e3181efa1b2.
Pina LS, Bouckaert F, Obbels J, Wampers M, Simons W, Wyckaert S, et al. Maintenance Electroconvulsive Therapy in Severe Bipolar Disorder: A Retrospective Chart Review. J ECT. 206;32:23-28. doi: 10.1097/YCT.0000000000000253.
Sienaert P, Peuskens J. Electroconvulsive therapy: an effective therapy of medication-resistant bipolar disorder. Bipolar Disord. 2006; 8:304-306. doi: 10.1111/j.1399-5618.2006.00317.x.
Weiner RD, Reti IM. Key updates in the clinical application of electroconvulsive therapy. Int Rev Psychiatry. 2017; 29:54-62. doi: 10.1080/09540261.2017.1309362.
Elias A, Phutane VH, Clarke S, Prudic J. Electroconvulsive therapy in the continuation and maintenance treatment of depression: Systematic review and meta-analyses. Aust N Z J Psychiatry. 2018;52:415–424. doi: 10.1177/0004867417743343.
Gill SP, Kellner CH. Clinical Practice Recommendations for Continuation and Maintenance Electroconvulsive Therapy for Depression: Outcomes From a Review of the Evidence and a Consensus Workshop Held in Australia in May 2017. J ECT. 2019;35:14-20. doi: 10.1097/YCT.0000000000000484.
Ross EL, Zivin K, Maixner DF. Cost-effectiveness of Electroconvulsive Therapy vs Pharmacotherapy/Psychotherapy for Treatment-Resistant Depression in the United States. JAMA Psychiatry. 2018;75:713-722. doi: 10.1001/jamapsychiatry.2018.0768.
National Institute for Health and Care Excellence. Guidance on the use of electroconvulsive therapy [TA59]. 2003 https://www.nice.org.uk/guidance/ta59
McDonald W. Is ECT cost-effective? A critique of the National Institute of Health and Clinical Excellence's report on the economic analysis of ECT. J ECT. 2006;22:25-29. doi: 10.1097/00124509-200603000-00005.
Fink M. Challenges to British practice of electroconvulsive therapy. J ECT. 2006;22:30-32. doi: 10.1097/00124509-200603000-00006.
Vallejo-Torres L, Castilla I, González N, Hunter R, Serrano-Pérez P, Perestelo-Pérez L. Cost-effectiveness of electroconvulsive therapy compared to repetitive transcranial magnetic stimulation for treatment-resistant severe depression: a decision model. Psychol Med. 2015;45:1459-1470. doi: 10.1017/S0033291714002554.
Mota J, Rodrigues-Silva N. Mirror-Image Study of Maintenance Electroconvulsive Therapy. J ECT. 2016;32:119-121. doi: 10.1097/YCT.0000000000000289.
Hayasaka Y, Purgato M, Magni LR, Ogawa Y, Takeshima N, Cipriani A, et al. Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials. J Affect Disord. 2015;180:179-184. doi: 10.1016/j.jad.2015.03.021.
Gardner DM, Murphy AL, O'Donnell H, Centorrino F, Baldessarini RJ. M.A., O'Donnell H, Centorrino F, Baldessarini RJ. International consensus study of antipsychotic dosing. Am J Psychiatry. 2010;167:686-6983. doi: 10.1176/appi.ajp.2009.09060802.
Rothe PH, Heres S, Leucht S. Dose equivalents for second generation long-acting injectable antipsychotics: The minimum effective dose method. Schizophr Res. 2018;193:23-28. doi: 10.1016/j.schres.2017.07.033.
MECTA-Corporation. MECTA instruction manual - optimized 200 joules international. 10th ed. 2012.
Navarro V, Gastó C, Torres X, Masana G, Penadés R, Guarch J, et al. Continuation/maintenance treatment with nortriptyline versus combined nortriptyline and ECT in late-life psychotic depression: A two-year randomized study. Am J Geriatr Psychiatry. 2008;16:498-505. doi: 10.1097/JGP.0b013e318170a6fa.
Nordenskjöld A, von Knorring L, Ljung T, Carlborg A, Brus O, Engrström I. Continuation electroconvulsive therapy with pharmacotherapy versus pharmacotherapy alone for prevention of relapse of depression: A randomized controlled trial. J ECT. 2013;29:86-92. doi: 10.1097/YCT.0b013e318276591f.
Vanelle JM, Loo H, Galinowski A, de Carvalho W, Bourdel MC, Brochier P, et al. Maintenance ECT in intractable manic-depressive disorders. Convuls Ther. 1994;10:195-205.
Cosculluela A, Cobo J, Martínez-Amorós E, Paños M, Santiago AM, Crivillés S, et al. Effectivity and Cost-effectivity of the Maintenance Electroconvulsive Therapy: A mirror naturalistic analysis. Actas Esp Psiquiatr. 2017;45:257-267.
Rodriguez-Jimenez R, Bagney A, Torio I, Caballero M, Ruiz P, Rivas F, et al. Clinical usefulness and economic implications of continuation/maintenance electroconvulsive therapy in a Spanish National Health System public hospital: A case series. Rev Psiquiatr Salud Ment. 2015;8:75-82. doi: 10.1016/j.rpsm.2014.10.002.
Steffens DC, Krystal AD, Sibert TE, Moore SD, Weiner RD. Cost effectiveness of maintenance ECT. Convuls Ther. 1995;11:283-284.
